chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had sore arm on the second day after receiving the vaccine. Lasted 3 days.  Running nose lasted 4days.
PATIENT BECAME DIZZY AND ELEVATED HEART RATE (120) PATIENT OBSERVED AN EXTRA 15 MINS  PATIENT SYMTOMS RESOLVED
High temperature, behavioral changes, drowsiness, green runny nose, green goop in eyes, irritability, sleeplessness, cough.
Fever; Extreme fatigue; Headache; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EZ6207) via an unspecified route of administration, on 19Mar2021, at 15:30, (at the age of 58 years) via unspecified route of administration, on left arm, as a single dose for COVID-19 immunisation. Medical history included high blood pressure and milk allergy. Concomitant medications were unspecified. The patient did not receive any other vaccine within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201) via an unspecified route of administration, on 26Feb2021, at 15:30, on left arm, as a single dose for COVID-19 immunisation. On 20Mar2021, at 12:00, the patient experienced fever, fatigue and headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The clinical outcome of event fever, fatigue and headache was recovering at the time of this report. No follow-up attempts are possible. No further information is expected.
Pt recvd vax & 12 hrs p/vax exp insomnia, nausea, sweat, achy joints & chest pressure which subsided;
unable to lay down on either side; unable to breathe easily; upset stomach; chest pain - in the middle of her of her chest; coldness from her neck to her stomach; diarrhea; sore throat; body aches; headache; chills; fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), OROPHARYNGEAL PAIN (sore throat), CHEST PAIN (chest pain - in the middle of her of her chest), FEELING COLD (coldness from her neck to her stomach) and DYSPNOEA (unable to breathe easily) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (body aches), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever). On 13-Feb-2021, the patient experienced DIARRHOEA (diarrhea) and OROPHARYNGEAL PAIN (sore throat). On 15-Feb-2021, the patient experienced CHEST PAIN (chest pain - in the middle of her of her chest), FEELING COLD (coldness from her neck to her stomach) and ABDOMINAL DISCOMFORT (upset stomach). On 17-Feb-2021, the patient experienced DYSPNOEA (unable to breathe easily). On an unknown date, the patient experienced INSOMNIA (unable to lay down on either side). On 14-Feb-2021, DIARRHOEA (diarrhea) and OROPHARYNGEAL PAIN (sore throat) had resolved. At the time of the report, CHEST PAIN (chest pain - in the middle of her of her chest), FEELING COLD (coldness from her neck to her stomach), DYSPNOEA (unable to breathe easily), ABDOMINAL DISCOMFORT (upset stomach), INSOMNIA (unable to lay down on either side), MYALGIA (body aches), HEADACHE (headache), CHILLS (chills) and PYREXIA (fever) had resolved.            No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Significant-Events resolved
Tactile hallucination of paralysis. High fever. Incoherence. Lasted a few hours.
Patient presented with infection of lymph node to MD shortly after vaccination. Treated with AUGMENTIN 875/125 every one Q 12 hours x 10 days.
Soreness in left arm near injection site and slight nausea. Nausea persisted for 6 hours as with the pain in the injection site.
About 24 hours after receiving the vaccine I woke up with a fever, headache, bodyaches and fatigue.  Symptoms resolved with Tylenol.   The next day symptoms continued along with lymph node pain in the right armpit.  All symptoms resolved by day 3 post injection.   Also note, I was symptomatic and tested positive in August with all of the previously stated symptoms except for lymph node pain.  Symptoms post vaccine were much more mild than the actual infection with covid.
On 09/24/2022, in the evening, my hair started aggressively, actively falling out. I messaged my dermatologist.  I stated steroid injections in my scalp that month.  I had been diagnosed with Alopecia, but it was in remission for over a year, and after the vaccine, it all came falling out again. I am on Prednisone and Methotrexate.
Complete sudden hearing loss in right ear about 50 hours after the first dose. Vaccination: 11/19/20201 ~ 3:30 pm, Adverse event: 11/21/2021 ~ 5:30pm, had a pediatrician's appointment at 2:50pm on 11/23/2021. Ear exam showed no blockages, fluid, or infection. Ear drum was intact. Performed hearing test. Left ear was normal, could not hear anything in the right ear. Follow-up appointment scheduled for 12/7 with Audiology at local hospital
Pain to injection site immediately following injection. Hot/ red injection site 7 days after injection. Swollen painful lymph node under arm pit of left arm (same side as injection)
Information has been received from a consumer concerning her 72 year old male cousin who in July 2008 (2 years ago), was vaccinated with ZOSTAVAX (Merck). 6 months later, in January 2009 the patient experienced shingles. The patient had fully recovered from shingles. No further information is available.
After my second dose I became tachycardic. My BP hasn't come down below 150/112. My resting heart rate stays at 95 or above. I have had a headache EVERY DAY since.
Decreased level of consciousness and red swollen area where injection was given the size about 3" diameter.
Immediately after receiving vaccine patient started to feel nervous and anxious. No trouble breathing.  Patient says she suffers with this normally and often have panic attacks. Gave patient some water and pretzels since she had not eaten anything all day. After 15 minutes observation period patient was fine.
1st dose in 2021, late 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 14th July 2021, (batch number 2LC3P,expiry date 15th November 2022)).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.    Additional Information: GSK Receipt Date: 01-NOV-2022 Reporter's Comments:  The patient reported that she had her first dose of Shingrix on 14th July 2021 at her MD's office, but never received her second dose. The patient mentioned she intended on getting her second dose as soon as possible.  The reporter consented to follow up. Patient gave her physician information.  Additional Supportive Information: Till the time of reporting the patient did not receive 2nd dose of vaccine, which led to incomplete course of vaccination. This case was identified as duplicate of case US2022158140. All future correspondence would be added in case US2022158123, which stands as case of record for this patient and the case US2022158140 would be deleted.
Large swelling at injection site (slightly larger than golf ball hard lump) with pain, and burning sensation down left forearm (injection side)
Administerd vaccine that was not stored in recommended temprature; A report was received from a health care professional concerning a 30-year old patient participating in the mRNA-1273 Emergency Use Program who was administered vaccine that was not stored in recommended temperature.  The patient's medical history was not provided. No relevant concomitant medications were reported.   The patient received their first of two planned doses of mRNA-1273 (Lot 011J20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection on 21 Dec 2020. On the same day, the nurse noticed administered vaccine was not stored in recommended temperature. Temperature reading of -21.6 and -20.9 ranges were in Fahrenheit instead of Celsius as the freezer reading was set to Fahrenheit. The nurse called to inquire whether the vaccine is usable. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, administered vaccine that was not stored in recommended temperature, was unknown.   The reporter did not provide an assessment for the event of administered vaccine that was not stored in recommended temperature.; Reporter's Comments: This case concerns a 30-year-old patient who received their first of two planned doses of mRNA-1273 (Lot 011J20A), reporting Product storage error without any associated adverse events.
Patient received immunization from vial containing diluent in the amount of 1.0 rather than 1.8 ml 0.9% sodium chloride, so dose was concentrated.
This incident was a vaccine error.  A vial of Moderna COVID-19 vaccine was used after the 12-hour window for beyond use date and time had expired.  The vial was initially punctured July 30th, 2021 at approximately 4:45pm EST.  The patient has not reported any adverse events at this time.
9 hours after injection: Uncontrollable shivers followed by feelings of unbearable ?dry? warmth?.  No sweating, just feeling on fire HOT.   This continued for 24 hours.  Headache? all over started around hour 24.  Fever of 102.5 started about hour 24.  Body aches, stiffness, cough all started around hour 30.  Hour 46? fever has broken, but headache & body aches still present.  Rotated/stacked 1000 mg acetaminophen q8 hrs and 800 mg ibuprofen q6 hrs
Sore arm; This is a spontaneous report from a contactable nurse (patient). A 24-year-old female patient (no pregnant at the time of vaccination) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EH9899) via intramuscularly on 22Dec2020 06:15 AM on left arm at single dose for COVID-19 immunization. The patient's medical history included hyperthyroidism/goiter and not allergy to medications, food, or other products. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and did not receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The concomitant drug included vitamins within 2 weeks of vaccination. The patient experienced sore arm on 22Dec2020 06:15 AM. No treatment for sore arm. The outcome of the events was recovering.
Rash and itching after exposed to heat  (bath, shower, heat in car) started day 20 after first dose. It?s happened three days in a row. No new soaps or changes.
About 12 hours after the shot I got severe chills and shaking, with a headache.  This lasted about 6 and a half hours, in spite of taking a Tylenol ever 4-5 hours after the shot.
This spontaneous report as received from a healthcare professional refers to an unspecified number of patients of unknown age. On an unknown date, improperly stored VAQTA 25/0.5 U/ml (dose, lot# and expiration date unspecified) that was exposed to 49F and 28F over a period of 5 days, was administered to an unknown number of patients on unknown dates. No adverse symptoms were reported. Additional information has been requested.
Child received third H1N1 flu vaccine at school on 1/15/10. Previous two dose given 12/11/09 & 1/11/10 at doctor's office unknown at that time. Parent forgot about consenting to vaccine to be given at school.
CONFIRMED IMMUNOLOGICAL VACCINE FAILURE; This spontaneous report received from a patient concerned a 60 year old female. The patient's weight was 118 pounds, and height was 62 inches. The patient's concurrent conditions included: primary immunodeficiency along with 3 to 4 other autoimmune diseases, dog allergy, cat allergy, and iodine allergy, and other pre-existing medical conditions included that he patient had allergy to various medications. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown expiry: unknown) dose was not reported, 1 total administered on 08-APR-2021 on left arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 14-MAY-2021, the patient tested positive for the Protein receptor binding domain (antibody) test (SARS-CoV-2 ELISA (Enzyme linked Immunoassay) test) (NR: not provided) 25.3. On 02-AUG-2021, the patient tested negative for SARS CoV-2 s1 IgA (Immunoglobulin A) IgG (Immunoglobulin G) test (SARS-CoV-2 IgA antibody test) (SARS-CoV-2 IgG antibody test) (NR: not provided) 0.13 (confirmed immunological vaccine failure).  The patient visited to the physician office. The immunologist suggested for a second shot of the Janssen Covid-19 (Corona virus) Vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccine failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210842932-COVID-19 VACCINE AD26.COV2.S-confirmed immunological vaccine failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 UNSPECIFIED ANXIETY DISORDER I23.7 POSTINFARCTION ANGINA 12/1/2021 UNSPECIFIED ANXIETY DISORDER I95.9 HYPOTENSION 5/2/2022 UNSPECIFIED ANXIETY DISORDER J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 UNSPECIFIED ANXIETY DISORDER I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 DM 2 W KETOACIDOTIC COMA I23.7 POSTINFARCTION ANGINA 12/1/2021 DM 2 W KETOACIDOTIC COMA I95.9 HYPOTENSION 5/2/2022 DM 2 W KETOACIDOTIC COMA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 DM 2 W KETOACIDOTIC COMA I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 POSTINFARCTION ANGINA I23.7 POSTINFARCTION ANGINA 12/1/2021 POSTINFARCTION ANGINA I95.9 HYPOTENSION 5/2/2022 POSTINFARCTION ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 POSTINFARCTION ANGINA I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 DYSARTHRIA    PRESENCE OF URETERAL STENT I23.7 POSTINFARCTION ANGINA 12/1/2021 DYSARTHRIA    PRESENCE OF URETERAL STENT I95.9 HYPOTENSION 5/2/2022 DYSARTHRIA    PRESENCE OF URETERAL STENT J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 DYSARTHRIA    PRESENCE OF URETERAL STENT I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 URETERAL STENT INFECTION, INIT I23.7 POSTINFARCTION ANGINA 12/1/2021 URETERAL STENT INFECTION, INIT I95.9 HYPOTENSION 5/2/2022 URETERAL STENT INFECTION, INIT J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 URETERAL STENT INFECTION, INIT I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 HOSPITAL ACQUIRED PNEUMONIA I23.7 POSTINFARCTION ANGINA 12/1/2021 HOSPITAL ACQUIRED PNEUMONIA I95.9 HYPOTENSION 5/2/2022 HOSPITAL ACQUIRED PNEUMONIA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 HOSPITAL ACQUIRED PNEUMONIA I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 GENERALIZED ANXIETY DISORDER I23.7 POSTINFARCTION ANGINA 12/1/2021 GENERALIZED ANXIETY DISORDER I95.9 HYPOTENSION 5/2/2022 GENERALIZED ANXIETY DISORDER J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 GENERALIZED ANXIETY DISORDER I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 EHLERS DANLOS SYNDROME I23.7 POSTINFARCTION ANGINA 12/1/2021 EHLERS DANLOS SYNDROME I95.9 HYPOTENSION 5/2/2022 EHLERS DANLOS SYNDROME J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 EHLERS DANLOS SYNDROME I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I23.7 POSTINFARCTION ANGINA 12/1/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I95.9 HYPOTENSION 5/2/2022 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA I21.4 ACUTE NON ST ELEVATION MI 12/24/2021 ACUTE NON ST ELEVATION MI I23.7 POSTINFARCTION ANGINA 12/1/2021 ACUTE NON ST ELEVATION MI I95.9 HYPOTENSION 5/2/2022 ACUTE NON ST ELEVATION MI J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/28/2021 ACUTE NON ST ELEVATION MI
Information has been received from a pharmacist, and via a company rep, concerning a pt (age and gender not reported) with an unk medical history, who within the past 6 weeks was vaccinated (route unk) with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot number not reported). The reporting pharmacist indicated that within the past 6 weeks the pt developed cellulitis. The pharmacist reported that the pt may have received the vaccine from a multi dose vial or from a single dose vial. The pt was admitted to the hospital because of the reaction but no details were provided. Outcome was not reported. No product quality complaint was involved. Additional information has been requested.
In am hardened lump to right deltoid with 3 centimeters        redness with warmth following. One day on 07/21/2006 reaction occurred 18 hours after injection. Has had loose stool for 4 days with nausea 07-22-2006-07-23-2006.  Patient has been applying ice.
Child in for XXX visit. Vaccines ordered for 4 month old child. DTaP, IPV, HIB, PNEUMOCOCCOL, and RROAVIRUS ordered by provider. RN administered DTaP + IPV combo vaccine Kinrix to child. GlaxoSmithKline Lot # H9FMS NDC-58160-812-43 0.5mL. RN will double check orders. RN will review immunization schedule and age appropriate vaccines. RN will order own vaccines in future. RN will monitor closely when training other nurses.
Pt was getting an Adacel vaccination and fainted.  Collapsed backward in chair without injury.  after about 10-15 seconds returned to conciousness.  Provided bottled water, ice pack and towel, and instructed pt to let me know if he needed anything more.  Pt had warned beforehand that he has gotten lightheaded with vaccinations, and even said he would faint before he did.  After about 15 minutes he got up and left, responding when asked that he was now doing fine.
Information has been received from a pharmacist referring to unspecified patients of unknown age and gender. There was no medical history or concurrent condition reported. On unknown dates, the patients were vaccinated with doses of ZOSTAVAX (lot#, dose, dose number, route were unspecified). Then on unspecified dates, the patients had a red, swollen area the size of a quarter at the ZOSTAVAX injection site. The pharmacist did not have any further information to provide regarding these patients. The outcome of the event was unknown. This is one of the two reports that received from the same reporter. Additional information has been requested.
A week after the injection a skin rash appeared under both arm pits, behind both knees and in one elbow.  Later in the day much smaller rash spots accrued on my wrist, chest, and neck.  Benadryl stopped the itching - now 4 days later all spots are gone except the most intense spot under one arm pit but it is decreasing daily and as of this am no longer itches
Severe headaches; This is a spontaneous report from a contactable consumer from a Pfizer Sponsored Program. A patient of unspecified age and gender received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 30Dec2020 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced severe headaches on an unspecified date. The event outcome was unknown.   Information on the lot/batch number has been requested.
Pt reported that she got Zostavax on 10/18/12 & Flu shot on 9/25/12. Reports burning sensation in arms and legs involving shoulder, forearm & thigh, this started 2 days after she got Zostavax vaccine. Improved in 2/13, but in 3/13 got worse. On a scale out of 10 her burning is rated a 5-6.
Swelling and pain in armpit area of right arm where the shot was given.  Was mild after first does but is worse after 2nd dose.
This spontaneous report as received from an other health professional (certified medical assistant) refers to a 49 year old female patient with penicillin drug reactions/allergies. In approximately 1996 (reported as 17 years ago) the patient was vaccinated with her first dose of VARIVAX (Merck). Dosing information, route of administration and lot number were not provided. Concomitant therapies included atorvastatin, diltiazem and quinapril. The patient, who worked with children, had varicella titers drawn on 05-SEP-2013. The varicella titers were negative. No treatment was given. Event outcome and causality assessment were not provided. Additional information has been requested.
Shingles after jab/Suspected vaccination failure; Shingles / side effects/ going on more than 4 months now; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 27-Feb-2023 Reporter's comment: The case was received from the patient's sibling via interactive digital media. The reporter reported that it was one of the side effects from taking the shot. The patient never had the shingles till, after taking the jab. The patient going on more than 4 months now. The reporter reported they (reporter's brother and cousin) both took the same one and it was sad, so any were duped including you. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available. The case was linked with case US2023AMR036588, reported by same reporter for different patient.; Sender's Comments:  US-GSK-US2023AMR036588:Same reporter
Dizziness, Fainting, gray color. Sister and brother also felt dizzy and "not well" after Flu Mist administered on 12/05/2015.
pt had a positive COVID test 12/11/2020 and states he's declined since then with weakness and SOB; had 2nd COVID vaccine 4/14/21; per death certificate "History of COVID infection" is a contributing cause of his death; pt died at home getting care at home
Developed terrible headache and screeching in my ears. Terrible for 2 days and a bit better now. Intensity fluctuates but is not resolved. I have been using allergy pills, tylenol and nasal spray. I saw my MD yesterday and she indicated my right ear drum is bulging. I do have a history of tinnitus but it has always been very soft. This has been significant. I am not able to sleep well and I am waking up because I think I hear our house alarm going off.